| MTX | Methotrexate |
| MTX-PG | Methotrexate polyglutamate |
| IMID | Immune-mediated inflammatory diseases |
| Ped-ALL | Pediatric acute lymphoblastic leukemia |
| RA | Rheumatoid arthritis |
| JIA | Juvenile idiopathic arthritis |
| CD | Crohn’s diseases |
| FPGS | Folyl-polyglutamate synthetase |
| TDM | Therapeutic drug monitoring |
| SNP | Single nucleotide polymorphism |
| S.C. | Subcutaneous |
| I.V. | Intravenous |
| I.Th. | Intrathecal |
| DMARD | Disease-modifying anti-rheumatic drugs |
| HCQ | Hydroxychloroquine |
| SSZ | Sulfasalazine |
| UPLC-MS/MS | Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry |
| BMI | Body mass index |
| BSA | Body surface area |
| eGFR | Estimated glomerular filtration rate |
| CKD-EPI | Chronic Kidney Disease Epidemiology Collaboration |
| MICE | Multiple imputation by chained equations |
| SD | Standard deviation |
| IQR | Interquartile range |
| AO | Aldehyde oxidase |
| RFC | Reduced folate carrier |
| Km | Michaelis constant |